aberrations and in good shape ample to tolerate FCR therapy, should be excellent candidates with the latter, Together with the benefit staying that this remedy is usually finished in six months while ibrutinib have to be taken indefinitely.Some diploma of immunophenotype overlap amongst CLL, marginal zone lymphoma, and lymphoplasmacytic lymphoma ex